Spatial colocalization and combined survival benefit of natural killer and CD8 T cells despite profound MHC class I loss in non-small cell lung cancer
Remziye E. WesseliD, Nardin Ageeb, Joseph Mounir ObeidiD, Ileana Soto MauldiniD, Kate A. Goundry, Gabriel F. HansoniD, Mahdin Hossain, Chad Lehman, Ryan D. GentzleriD, Nolan A. WagesiD, Craig Lee SlingluffiD, Timothy N. J. BullockiD, Sepideh DolatshahiiD, Michael G. BrowniD
Abstract
BackgroundMHC class I (MHC-I) loss is frequent in non-small cell lung cancer (NSCLC) rendering tumor cells resistant to T cell lysis. NK cells kill MHC-I-deficient tumor cells, and although previous work indicated their presence at NSCLC margins, they were functionally impaired. Within, we evaluated whether NK cell and CD8 T cell infiltration and activation vary with MHC-I expression. MethodsWe used single-stain immunohistochemistry (IHC) and Kaplan-Meier analysis to test the effect of NK cell and CD8 T cell infiltration on overall and disease-free survival. To delineate immune covariates of MHC-I-disparate lung cancers, we used multiplexed immunofluorescence (mIF) imaging followed by multivariate statistical modeling. To identify differences in infiltration and intercellular communication between IFN{gamma}-activated and non-activated lymphocytes, we developed a computational pipeline to enumerate single cell neighborhoods from mIF images followed by multivariate discriminant analysis ResultsSpatial quantitation of tumor cell MHC-I expression revealed intra- and inter-tumoral heterogeneity, which was associated with the local lymphocyte landscape. IHC analysis revealed that high CD56+ cell numbers in patient tumors were positively associated with disease-free survival (DFS) (HR=0.58, p=0.064) and over-all survival (OS) (HR=0.496, p=0.041). The OS association strengthened with high counts of both CD56+ and CD8+ cells (HR=0.199, p View larger version (36K): org.highwire.dtl.DTLVardef@1e383c0org.highwire.dtl.DTLVardef@1dee268org.highwire.dtl.DTLVardef@1e21bd4org.highwire.dtl.DTLVardef@1910a9f_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 22
- FWCI
- 3.77
- Field percentile
- top 5%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cancer cell-specific MHCII expression as a determinant of the immune infiltrate organization and function in the non-small cell lung cancer tumor microenvironment
A. M. Johnson, J. M. Boland, … E. L. Schenk·bioRxiv·Feb 24, 2021
- Tertiary lymphoid structure-related immune infiltrates in NSCLC tumor lesions correlate with low tumor-reactivity of TIL products
Suzanne M. Castenmiller, Nandhini Kanagasabesan, … Monika C. Wolkers·OncoImmunologyPeer-reviewed·Aug 22, 2024
- Tumor-infiltrating natural killer cell profiling for therapeutic stratification in patients with resectable non-small cell lung cancer
Atsushi Ito, Sung Wook Kang, … Hyun-Sung Lee·Journal of Thoracic and Cardiovascular SurgeryPeer-reviewed·Mar 4, 2026
- Contribution of resident and circulating precursors to tumor-infiltrating CD8+ T cell populations in non-small cell lung cancer patients
C. Metoikidou, P. Gueguen, … S. Amigorena·bioRxiv·Aug 14, 2020
- Polyfunctional tumor-reactive T cells are effectively expanded from non-small cell lung cancers, and correlate with an immune-engaged T cell profile
R. de Groot, M. M. van Loenen, … M. C. Wolkers·bioRxiv·Jun 8, 2019
- Distinct Spatial Immune Architectures in Tumor and Tumor-Adjacent Tissues of Early-Stage Non-Small Cell Lung Cancer
Isabella Polic, Claudio A. Arrechedera, … Alexandre Reuben·bioRxiv·Sep 14, 2026